{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:17:00Z","timestamp":1774916220183,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Solid-organ transplant recipients (SOTRs) have a higher risk of coronavirus disease 2019 (COVID-19) complications and death and a less powerful and lasting response to vaccines and to natural infection. In Colombia, this population was prioritized in the National Vaccination Plan against COVID-19 and received vaccines from different platforms. The aim of this study was to estimate the effectiveness of the complete vaccination schedule and of the vaccine booster for COVID-19 administered to SOTRs in Colombia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>A nested-cohort was assembled within the population-based ESPERANZA cohort and included the subset of 16 y and older SOTRs (n = 6963); the follow-up period spanned March 11, 2021, to May 11, 2022. The vaccine effectiveness was estimated with Cox proportional-hazards models so that the overall effectiveness of the complete vaccination schedule, the vaccine booster, each used vaccine, and the homologous and heterologous schedules were estimated, adjusting by the main confounders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The overall effectiveness of being fully vaccinated was 73.7% (95% confidence interval [CI], 68.9%-77.0%) to prevent COVID-19 infection, 83.7% (95% CI, 78.7%-87.5%) to prevent hospitalization, and 92.1% (95% CI, 88.8%-94.4%) to prevent death due to COVID-19. Similarly, the effectiveness of the vaccine booster was 76.7% (95% CI, 70.6%-81.5%), 86.9% (95% CI, 79.4%-91.6%), and 94.5% (95% CI, 89.8%-97.1%) to prevent confirmed COVID-19 infection, hospitalization, and death due to COVID-19, respectively. In both cases, there were no statistically significant differences across age groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Findings from this work show a high protection of vaccination against infection, hospitalization, and death due to COVID-19 in SOTRs, which increases with the vaccine booster.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004411","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T22:00:08Z","timestamp":1665698408000},"page":"216-224","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Real-world Evidence of COVID-19 Vaccines Effectiveness in Solid-organ Transplant Recipient Population in Colombia: A Study Nested in the Esperanza Cohort"],"prefix":"10.1097","volume":"107","author":[{"given":"Mariana","family":"Pinto-\u00c1lvarez","sequence":"first","affiliation":[{"name":"Direcci\u00f3n de Medicamentos y Tecnolog\u00edas de Salud, Ministerio de Salud y Protecci\u00f3n Social, Bogot\u00e1 DC, Colombia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n A.","family":"Fern\u00e1ndez-Ni\u00f1o","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD."},{"name":"Departamento de Salud P\u00fablica, Universidad del Norte, Barranquilla, Colombia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Arregoc\u00e9s-Castillo","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Medicamentos y Tecnolog\u00edas de Salud, Ministerio de Salud y Protecci\u00f3n Social, Bogot\u00e1 DC, Colombia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maylen L.","family":"Rojas-Botero","sequence":"additional","affiliation":[{"name":"Facultad Nacional de Salud P\u00fablica, Universidad de Antioquia, Medell\u00edn, Colombia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s F.","family":"Palacios","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Medicamentos y Tecnolog\u00edas de Salud, Ministerio de Salud y Protecci\u00f3n Social, Bogot\u00e1 DC, Colombia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryory","family":"Galvis-Pedraza","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Medicamentos y Tecnolog\u00edas de Salud, Ministerio de Salud y Protecci\u00f3n Social, Bogot\u00e1 DC, Colombia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Ruiz-Gomez","sequence":"additional","affiliation":[{"name":"Ministerio de Salud y Protecci\u00f3n Social, Bogot\u00e1 DC, Colombia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/ejhf.2199","article-title":"Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients\u2014a prospective cohort study.","volume":"23","author":"Itzhaki Ben Zadok","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"R7-20250604","article-title":"Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines.","author":"Prendecki","year":"2021","journal-title":"medRxiv"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mrna covid-19 vaccine in solid-organ transplant recipients.","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/ajt.16701","article-title":"Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients.","volume":"21","author":"Cucchiari","year":"2021","journal-title":"Am J Transplant"},{"key":"R10-20250604","first-page":"1136","article-title":"Anti\u2013SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.","volume":"100","author":"Bruminhent","year":"2021"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.7326\/L21-0282","article-title":"Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series.","volume":"174","author":"Werbel","year":"2021","journal-title":"Ann Intern Med"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"m1198","DOI":"10.1136\/bmj.m1198","article-title":"Covid-19: risk factors for severe disease and death.","volume":"368","author":"Jordan","year":"2020","journal-title":"BMJ"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients.","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M21-3480","article-title":"Neutralization of SARS-CoV-2 variants in transplant recipients after two and three doses of mRNA-1273 vaccine: secondary analysis of a randomized trial.","volume":"175","author":"Kumar","year":"2022","journal-title":"Ann Intern Med"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/joim.13361","article-title":"Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.","volume":"290","author":"Holden","year":"2021","journal-title":"J Intern Med"},{"key":"R17-20250604","article-title":"Cell-mediated and humoral immune response to 2-dose SARS-CoV2 mRNA vaccination in immunocompromised patient population.","author":"Ramanathan","year":"2021","journal-title":"medRxiv"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1016\/S2666-7568(22)00035-6","article-title":"Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort.","volume":"3","author":"Arregoc\u00e9s-Castillo","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12879-022-07418-y","article-title":"SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis.","volume":"22","author":"Ssentongo","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"752233","DOI":"10.3389\/fimmu.2021.752233","article-title":"Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination.","volume":"12","author":"Ali","year":"2021","journal-title":"Front Immunol"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/lt.26366","article-title":"Immunogenicity and adverse effects of the 2-dose BNT162b2 messenger RNA vaccine among liver transplantation recipients.","volume":"28","author":"Davidov","year":"2022","journal-title":"Liver Transpl"},{"key":"R26-20250604","article-title":"Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.","author":"Jurdi A","year":"2022","journal-title":"medRxiv"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines10010037","article-title":"COVID-19 vaccines cost-effectiveness analysis: a scenario for Iran.","volume":"10","author":"Vaezi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"e1003815","DOI":"10.1371\/journal.pmed.1003815","article-title":"COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness.","volume":"18","author":"Pearson","year":"2021","journal-title":"PLOS Med"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1038\/s41467-021-26557-5","article-title":"Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa.","volume":"12","author":"Reddy","year":"2021","journal-title":"Nat Commun"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/S2665-9913(22)00127-8","article-title":"Immunosuppression and SARS-CoV-2 breakthrough infections.","volume":"4","author":"Kim","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1432-2277.2007.00631.x","article-title":"Immune responsiveness and protective immunity after transplantation.","volume":"21","author":"Gangappa","year":"2008","journal-title":"Transpl Int"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"e56974","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after solid organ transplantation: a systematic review.","volume":"8","author":"Eckerle","year":"2013","journal-title":"PLoS One"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.clinthera.2017.07.005","article-title":"A Comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients.","volume":"39","author":"Chong","year":"2017","journal-title":"Clin Ther"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"e13705","DOI":"10.1111\/tid.13705","article-title":"Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.","volume":"23","author":"Aslam","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciab438","article-title":"The effectiveness of the two-dose BNT162b2 vaccine: analysis of real-world data.","volume":"74","author":"Chodick","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciab687","article-title":"Effectiveness of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United States.","volume":"74","author":"Tenforde","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/ajt.16950","article-title":"Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients.","volume":"22","author":"Kamar","year":"2022","journal-title":"Am J Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"e068632","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of Covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.2021.12339","article-title":"Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses.","volume":"326","author":"Benotmane","year":"2021","journal-title":"JAMA"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:16:50Z","timestamp":1749061010000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004411","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}